Global colorectal cancer screening market to reach $46.1b by 2029

It is driven by rising number of colorectal cancer cases.

The global colorectal cancer screening and diagnostics market is projected to grow from $40b in 2024 to $46.1b by 2029, according to a new report from BCC Research. This represents a compound annual growth rate (CAGR) of 2.9% over the forecast period.

Key factors driving growth include the rising number of colorectal cancer cases, particularly amongst younger adults; the high cost of treatment, which increases demand for cost-effective screening; and technological advances in genomics and molecular diagnostics that improve test accuracy and personalization.

Non-invasive screening methods, like stool and blood tests, are also gaining popularity, making early detection easier and more accessible.

The report also noted that early diagnosis reduces treatment costs and improves survival rates, further boosting demand for advanced screening technologies.